Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for IBS Clinical Trials
IBS clinical trials are recruiting across 40 cities. Here are the cities with the most active studies:
IBS Trial Phases
20 research organizations are sponsoring ibs trials.
About IBS
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder causing abdominal pain, bloating, and altered bowel habits. It affects 10-15% of the global population. Management includes dietary changes (low FODMAP diet), stress management, and medications targeting specific symptoms.
Clinical trials are advancing new treatments for ibs. Currently, 26 studies are recruiting a combined 3,836 participants across the United States. Research is being conducted by 20 organizations including Eli Lilly and Company, Seattle Children's Hospital, GlaxoSmithKline and 17 others.
2026 IBS Research Landscape
As of October 2026, the ibs clinical trial landscape includes 26 actively recruiting studies across 40 cities in the United States. These studies are collectively seeking 3,836 participants, with an average enrollment target of 148 per study.
The research spans multiple phases of development: 13 studies are in NA, 8 studies are in PHASE2, 1 study is in PHASE3, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some ibs treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 20 different organizations, including Eli Lilly and Company, Seattle Children's Hospital, GlaxoSmithKline, IBS-80, LLC, Mark Pimentel, MD, and 15 others. The large number of sponsors reflects significant research interest and investment in ibs treatment advancement.
Geographically, ibs trials are most concentrated in Los Angeles, California (4 trials); Ann Arbor, Michigan (4 trials); Anaheim, California (3 trials); Mesa, Arizona (2 trials); Lancaster, California (2 trials) and 7 other cities.
Featured IBS Studies
Highlighted recruiting studies for ibs, selected by enrollment size and research scope.
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin) when compared with placebo. The study will last approximately 35 weeks.
Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
The goal of this clinical trial is to test efficacy of the REACH program in parents with irritable bowel syndrome (IBS) and their young children. The main question it aims to answer is: -How can parents with IBS help their young kids develop healthy habits? Participants will be asked to complete online surveys and to use a website. Researchers will compare results from parents who use one of two...
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.
Frequently Asked Questions About IBS Clinical Trials
Are there ibs clinical trials near me?
Yes, there are 26 ibs clinical trials currently recruiting across 40+ cities in the United States, including Los Angeles, California; Ann Arbor, Michigan; Anaheim, California. Browse the studies above to find one at a location convenient for you.
How do I join a ibs clinical trial?
To join a ibs clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are ibs clinical trials free?
Yes, participation in ibs clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of ibs treatments are being studied?
Current ibs clinical trials are testing a range of approaches across NA (13 studies), PHASE2 (8 studies), PHASE3 (1 study), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 20 research organizations.
Is it safe to participate in ibs clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated October 12, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated October 12, 2026 · Data from ClinicalTrials.gov